邹梅珍，博士，校聘副教授。
湖北省楚天青年人才，武汉英才获得者。博士毕业于武汉大学，主持国家自然科学基金青年项目1项以及湖北省自然科学基金面上项目1项，参与国家自然科学基金2项。以第一作者及共同第一作者发表SCI论文11篇，包括Advanced Materials, Nature Communications, National Science Review, Nano Letters等。申请发明专利1项。
Email: [email protected]
研究领域
1. 生物医用材料用于肿瘤诊疗
2. 高分子材料的改性与生物应用
3. 代谢组学在肿瘤治疗中的相关应用
主持项目：
1. 国家自然科学基金青年项目: 级联靶向响应纳米系统用于结肠癌淋巴转移的个性化诊疗，30万
2. 湖北省自然科学基金一般面上项目：核壳纤维程序性调控肿瘤微环境用于提高肿瘤化疗与免疫治疗疗效的研究，8万
代表性论文
1. Zou, M. Z.*, Shen, C. F., Peng, W. T., Zhang, L, Liu, W. L. *, Lv, Y. G. *, A Biomimetic Nanoplatform with Mechano-metabolic Microenvironment and Hypoxic Microenvironment Programming Ability for Enhanced Chemo-immunotherapy. Chemical Engineering Journal. 2025, 513,163088
2. Liu, W. L., Cao, A-M, Li, H. R., Huo, Y., Qin, S. Y., Zhang, A. Q., Cheng, Y. J. *, and Zou, M. Z.*, Hydrogen Peroxide Independent Chemodynamic Therapy via Docosahexaenoic-Acid-Hydroperoxide Rich-Cytomembrane-Coated Magnetic Nanoparticles, ACS Applied Nano Materials 2024, 7 (1), 957−965.
3. Zou, M. Z. #; Li, Z. H.#; Liu, C. J.; Zhang, X. Z.*, Hybrid Vesicles Based on Autologous Tumor Cell Membrane and Bacterial Outer Membrane to Enhance Innate Immune Response for Personalized Tumor Immunotherapy. Nano Letters 2021, 21 (20),8609-8618.
4. Zou, M. Z. #; Liu, W. L. #; Chen, H. S.; Bai, X. F.; Gao, F.; Ye, J. J.; Cheng, H.; Zhang, X. Z.*, Advances on nanomaterials for treatment of hypoxic tumor. National Science Review 2021, 8 (2), nwaa160.
5. Zou, M. Z.; Liu, W. L.; Gao, F.; Bai, X. F.; Chen, H. S.; Zeng, X.; Zhang, X. Z.*, Artificial Natural Killer Cells for Specific Tumor Inhibition and Renegade Macrophage Re-Education. Advanced Materials 2019, 31 (43), 1904495.
6. Zou, M. Z.; Liu, W. L.; Li, C. X.; Zheng, D. W.; Zeng, J. Y.; Gao, F.; Ye, J. J.; Zhang, X. Z.*, A Multifunctional Biomimetic Nanoplatform for Relieving Hypoxia to Enhance Chemotherapy and Inhibit the PD-1/PD-L1 Axis. Small 2018, 14 (28), 1801120.
7. Liu, W. L. #; Zou, M. Z. #; Liu, T.; Zeng, J. Y.; Li, X.; Yu, W. Y.; Feng, J.*; Zhang, X. Z.*, Cytomembrane nanovaccines by mimicking tumor cells and antigen presenting cells. Nature Communications. 2019, 10(1), 3199.
8.Liu, W. L. #; Zou, M. Z. #; Liu, T.; Zeng, J. Y.; Li, X.; Yu, W. Y.; Feng, J.*; Zhang, X. Z.*, Expandable Immunotherapeutic Nanoplatforms Engineered from Cytomembranes of Hybrid Cells Derived from Cancer Cells and Dendritic Cell. Advanced Materials. 2019, 1900499.
